Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes. Lycke J Ther Adv Neurol Disord. 2015 Nov; 8(6):274-293. PMID: 26600872. Abstract CommentRecommendBookmarkWatch